BEUDAMED
    FDA Adverse Event Injury Summary report: N

    VANISHPOINT INSULIN SYRINGE U-100

    MDR report key: 5646264 · Received May 7, 2016

    Report

    Report Number
    MW5062186
    Event Type
    Injury
    Date Received
    May 7, 2016
    Date of Event
    May 7, 2016
    Report Date
    May 7, 2016
    Manufacturer
    RETRACTABLE TECHNOLOGIES, INC.
    Product Code
    MEG
    Product Problem
    Yes
    Report Source
    Voluntary report
    Reporter Location
    MO, US
    Reporter Occupation
    NURSE

    Narratives

    Description of Event or Problem · 1

    INSULIN SYRINGE RETRACTABLE POINT DID NOT FUNCTION. THE SYRINGE WE USE HAD MALFUNCTIONED SEVERAL TIMES FOR ME (THIS IS AT LEAST THE THIRD TIME) SINCE WE HAVE STARTED USING THEM. VANISHPOINT INSULIN SYRINGE NAFDAC #03-0623, REF (B)(4).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    294417 VANISHPOINT INSULIN SYRINGE U-100 VANISHPOINT INSULIN SYRINGE MEG RETRACTABLE TECHNOLOGIES, INC. U-100 15221

    Patients

    Seq Age Sex Outcome Treatment
    1 61 YR Required Intervention